The pathways of bile acid synthesis in man were evaluated by studying the metabolism of 7α-hydroxycholesterol-4-14C and 26-hydroxycholesterol-16, 22-3H administered parenterally to individuals requiring external biliary drainage. Techniques for the identification of metabolites were thin-layer chromatography, column chromatography, gas-liquid chromatography with stream splitting, and crystallization to constant specific activity. It was found that both compounds were rapidly metabolized to bile acids and excreted in bile. Of the total radioactivity recovered in bile as bile acids, 87% of the 26-hydroxycholesterol-3H and 90% of the 7α-hydroxycholesterol-14C was found to be metabolized to both chenodeoxycholate and cholate. Compared to 7α-hydroxycholesterol, a greater proportion of 26-hydroxycholesterol was found to be metabolized to chenodeoxycholate.
Karl E. Anderson, Engeline Kok, Norman B. Javitt
Usage data is cumulative from November 2025 through November 2026.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 387 | 23 |
| 192 | 11 | |
| Scanned page | 472 | 2 |
| Citation downloads | 202 | 0 |
| Totals | 1,253 | 36 |
| Total Views | 1,289 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.